Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Fluocinonide topical preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluocinonide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone adverse reaction |
Causative agent (attribute) |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to fluocinolone |
Causative agent (attribute) |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinonide 500 microgram/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinonide 500 microgram/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide (substance) |
Is a |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide+clioquinol 0.025%/3% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide+clioquinol 0.025%/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluocinolone 0.59mg ocular implant |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluocinolone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing clioquinol and fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing fluocinolone in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluocinolone in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to fluocinolone |
Causative agent (attribute) |
False |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to fluocinolone |
Causative agent (attribute) |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone acetonide (substance) |
Is modification of (attribute) |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing fluocinolone and hydroquinone and tretinoin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Fluocinolone-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fluocinolone and neomycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only clioquinol and fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluocinolone and hydroquinone and tretinoin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only fluocinolone and neomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only fluocinolone and neomycin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only fluocinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fluocinolone and hydroquinone and tretinoin only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing fluocinolone and hydroquinone and tretinoin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only ciprofloxacin and fluocinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ciprofloxacin and fluocinolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Clioquinol and fluocinolone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ciprofloxacin and fluocinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluocinolone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ciprofloxacin and fluocinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing clioquinol and fluocinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Fluocinolone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |